Clinical Trial Update: EUS RFA for Treatment of Pancreatic Ductal Adenocarcinoma (PDAC) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating endoscopic ultrasound-guided radiofrequency ablation for pancreatic ductal adenocarcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Snippet

Sponsor: NYU Langone Health | Conditions: Pancreatic Cancer | Phase 1 | Status: RECRUITING